A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

NCT04671901 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Solid Tumor
Solid Tumor, Childhood
Solid Carcinoma

Interventions

DRUG: Romiplostim

Sponsor

Memorial Sloan Kettering Cancer Center